Cytek Biosciences (CTKB) Finished Goods (2020 - 2026)

Cytek Biosciences' Finished Goods history runs 7 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• Quarterly Finished Goods fell 35.54% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 35.54% YoY) and the FY2025 annual result came in at $11.5 million, down 22.78% from the prior year.
• Finished Goods was $9.8 million for Q1 2026 at Cytek Biosciences, down from $11.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $22.8 million in Q1 2023 and bottomed at $9.8 million in Q1 2026.
• A 5-year average of $15.9 million and a median of $15.3 million in 2022 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2022 — Finished Goods jumped 86.31% — and 2026, when it tumbled 35.54%.
• Cytek Biosciences' Finished Goods stood at $16.3 million in 2022, then dropped by 9.96% to $14.7 million in 2023, then advanced by 0.88% to $14.8 million in 2024, then decreased by 22.78% to $11.5 million in 2025, then declined by 14.36% to $9.8 million in 2026.
• Business Quant data shows CTKB's Finished Goods at $9.8 million in Q1 2026, $11.5 million in Q4 2025, and $20.3 million in Q3 2025.